Clinical Trial Update: Intermittent Fasting in Refractory Epilepsy [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating intermittent fasting for refractory epilepsy has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Snippet

Sponsor: University College London Hospitals | Conditions: Epilepsy | Phase 2 | Status: TERMINATED